The Effects of Oral Vitamin D Supplement on Atopic Dermatitis: A Clinical Trial with Staphylococcus aureus Colonization Determination.
J Med Assoc Thai. 2015 Oct;98 Suppl 9:S23-30.
Udompataikul M, Huajai S, Chalermchai T, Taweechotipatr M, Kamanamool N.
Used 2,000 IU daily for 4 weeks
Even far better benefits expected if had used any/all of the following
- Loading dose – Consume 350,000 IU of vitamin D in a week
- Higher daily dose – say 4,000 IU
- Longer dosing period – say 8 or 12 weeks
See also VitaminDWiki
- Evidence indicating that vitamin D deals with microorganisms in atopic dermatitis – Jan 2015
- Atopic Dermatitis risk is 55 percent higher if low vitamin D – Meta-analysis Oct 2015
- Skin physiology, pathology and vitamin D - review Jan 2016 90% of Atopic Dermatitis have staph infection
- Staph infection reduced 50 percent when have more than 30 ng of vitamin D – Aug 2011
- MRSA inpatient cost 2X higher if less than 20 ng vitamin D – June 2011
MRSA = Methicillin Resistant Staphylococcus Aureus
- Vitamin D reduces sepsis
An increase in Staphylococcus aureus skin colonization in atopic dermatitis patients resulted from the reduction of cathelicidin production in these patients. Recently, an in vivo study demonstrated that vitamin D could stimulate cathelicidin production. Oral supplements of vitamin D might be beneficial in atopic dermatitis.
To determine the effects of oral vitamin D supplements on clinical impact including Staphylococcus aureus skin colonization evaluation in atopic dermatitis patients.
MATERIAL AND METHOD:
Twenty-four atopic dermatitis patients were included in this double-blind, placebo-controlled study. They were randomly assigned into 2 groups for oral 2,000 IUs/day of vitamin D, supplement and placebo. The lesional swab culture for S. aureus was done at week 0, 2 and 4. Clinical outcomes were assessed by SCORAD score, mexameter for erythema index and konometer for conductance were done at week 0, 2 and 4. Serum vitamin D levels were also determined at week 0 and 4.
Twenty patients completed the protocol. S. aureus skin colonization, SCORAD score and erythema index were significantly reduced from baseline to week 4 for vitamin D treated group comparing with placebo (p = 0.022, 0.028 and 0.014, respectively). There was an inverse correlation between serum vitamin D levels with S. aureus skin colonization and SCORAD score (r = -1.0, p < 0.001).
Oral vitamin D supplement could reduce skin colonization of S. aureus and demonstrated the clinical improvement of patients with atopic dermatitis.